Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

9,673 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Adaptive Biotechnologies Secures $105 Million In Financing

    Adaptive Biotechnologies has announced it has completed a series C financing round and completed a newly created series D round of financing.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Amedica Secures $26 Million In Financing

    Amedica, headquartered in Salt Lake City, is a spinal and orthopedic implant and instrument company focused on silicon nitride ceramic technologies.
    United StatesFood, Drugs, Healthcare, Life Sciences
McGuireWoods LLP
McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Ascend Partners Invests In Rendr

    Ascend Partners has completed an equity investment in Rendr, according to a news release.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Atreca Secures $56 Million In Funding

    Atreca, based in Redwood City, California, is a privately held biotechnology company developing therapeutics drawn from human immune responses, including anti-cancer immune responses.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital To Acquire Harrington Process Solutions

    Bain Capital Private Equity will acquire Harrington Process Solutions, according to a news release.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Benvenue Medical Secures $64 Million In Financing

    Benvenue Medical has announced it completed a $64 million round of financing.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: BV Invests In Hardenbergh Group

    Hardenbergh Group, founded in 1991 and based in Livonia, Mich., is a provider of non-clinical professional staffing, consulting, physician...
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Daktari Diagnostics Secures $15.5 Million In Financing

    Daktari Diagnostics has announced it has closed a $15.5 million series D round of funding.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: DICOM Grid Secures $6 Million In Financing

    DICOM Grid, headquartered in Phoenix, Ariz., is a healthcare IT company that has made a cloud-based platform for medical image management and exchange.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: EndoGastric Secures $30 Million In Financing

    EndoGastric Solutions has announced it completed raising $30 million in an internal series G financing round.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Epic Sciences Secures $30 Million In Financing

    Epic Sciences, headquartered in San Diego, CA, is a biotech company developing diagnostic tests to molecularly characterize circulating tumor cells in the blood.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: FFL Invests In Johnson County Clin-Trials

    JCCT, based in Lenexa, Kan., is a clinical research site platform serving pharmaceutical and biotechnology companies and contract research organizations.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Galera Therapeutics Secures $37 Million In Financing

    Galera Therapeutics has announced it has raised $37 million in series B financing.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: GTCR To Acquire Cloudbreak Health For $180 Million

    GTCR has announced it will acquire Cloudbreak Health from UpHealth for $180 million.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Inspire Medical Systems Secures $40 Million In Financing

    Inspire Medical Systems has announced it completed raising $40 million in series E financing.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Intellia Therapeutics Secures $70 Million In Financing

    Intellia Therapeutics has announced it has secured $70 million in series B financing.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Invuity Secures $20 Million In Financing

    Invuity has announced it has raised $20 million in equity.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: KKR Acquires Therapy Brands

    KKR has announced it has closed previously announced acquisition of a majority interest in Therapy Brands.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Livongo Health Secures $20 Million In Financing

    Livongo Health has announced it has secured $20 million in series B funding.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Mederi Therapeutics Secures $18.5 Million In Funding

    Mederi Therapeutics Inc. has announced it has secured $18.5 million in funding comprised of Series B preferred stock and venture debt.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Showing 881–900 of 9673 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics